Valuation (17%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.31 | N/A |
PEG Ratio (TTM) | 0.05 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 8.85 | N/A |
P/FCF Ratio (TTM) | -18.59 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -43.56% | N/A |
ROE (TTM) | -456.67% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -92.09% | 857.04% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -195.55% | 21,089.14% | N/A |
Cash Flow | -23,864.92% | -124,635.29% | N/A |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.50 | N/A |
Quick Ratio (TTM) | 3.34 | N/A |
D/E Ratio (TTM) | 4.86 | N/A |
Interest Coverage (TTM) | -7.54 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |